Arcadia Biosciences, Inc. (RKDA)
NASDAQ: RKDA · Real-Time Price · USD
2.160
+0.190 (9.64%)
At close: Mar 9, 2026, 4:00 PM EDT
1.980
-0.180 (-8.33%)
After-hours: Mar 9, 2026, 7:59 PM EDT

Arcadia Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
48372334
Upgrade
Market Cap Growth
-37.72%132.51%-47.96%-71.05%-32.20%-28.18%
Upgrade
Enterprise Value
-22-11-14-834
Upgrade
Last Close Price
1.975.923.1310.8441.60101.20
Upgrade
PS Ratio
0.671.600.781.343.404.24
Upgrade
PB Ratio
0.491.300.270.320.741.19
Upgrade
P/TBV Ratio
0.641.310.270.320.751.26
Upgrade
EV/Sales Ratio
-0.34---4.24
Upgrade
Debt / Equity Ratio
-0.030.080.100.110.33
Upgrade
Net Debt / Equity Ratio
-1.08-0.66-0.84-0.89-0.81-0.57
Upgrade
Net Debt / EBITDA Ratio
0.990.561.912.761.090.99
Upgrade
Net Debt / FCF Ratio
0.970.420.701.330.950.50
Upgrade
Asset Turnover
0.430.300.180.140.150.20
Upgrade
Inventory Turnover
2.693.292.001.062.183.16
Upgrade
Quick Ratio
2.942.113.385.205.964.29
Upgrade
Current Ratio
3.673.614.176.037.025.02
Upgrade
Return on Equity (ROE)
-64.65%-45.62%-31.72%-14.62%-54.01%-32.68%
Upgrade
Return on Assets (ROA)
-31.48%-28.06%-15.04%-12.38%-33.30%-26.92%
Upgrade
Return on Capital Employed (ROCE)
-95.30%-68.10%-36.30%-29.20%-62.50%-42.00%
Upgrade
Earnings Yield
-146.45%-87.10%-402.29%-230.24%-63.54%-13.68%
Upgrade
FCF Yield
-175.94%-119.34%-440.21%-210.37%-116.48%-95.66%
Upgrade
Buyback Yield / Dilution
-0.28%-10.22%-106.37%-12.66%-113.68%-56.51%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.